How a good outcome might yet be salvaged from the UK drugs row
November 3, 2009 | by Alex Evans | More on Influence and networks, UK | No comments
The row in Britain over the sacking of Professor David Nutt, until last week the head of the head of the government’s Advisory Committee on the Misuse of Drugs (ACMD) shows little sign of abating: two members of the Committee have quit in Nutt’s support, and there’s talk of a mass resignation when the Committee meets on Monday. The reason for all the hoo-hah: Nutt’s public argument in a lecture (and a subsequent article) that the government had overstated the dangers of cannabis (as well as other drugs, like LSD or ecstasy), and that an evidence-based approach that prioritised harm reduction would see tobacco and alcohol as higher priorities. As he argued in his article,
I think we have to accept young people like to experiment, and what we should be doing is to protect them from harm at this stage of their lives. We therefore have to provide more accurate and credible information. We have to tell them the truth, so that they use us as their preferred source of information. If you think that scaring kids will stop them using, you’re probably wrong.
This was anathema as far as Alan Johnson was concerned, who promptly sacked Nutt on Friday last week, arguing that
Professor Nutt chose, without prior notification to my department, to initiate a debate on drugs policy in the national media … accusing my predecessor or distorting and devaluing scientific research. As a result, I have lost confidence in Professor Nutt’s ability to be my principal adviser on drugs.
More or less the entire UK scientific community is now up in arms about Nutt’s sacking: thus for example Lord Krebs, former head of the Food Standards Agency:
I thought it was an appalling decision and totally inappropriate … it will send shockwaves through the scientific community and make it more difficult for the government to recruit the best people to help with scientific advice to underpin public policy … not one person … has been other than horrified about it and feeling that this called into question the whole validity of the government’s approach to independent scientific advice.
While I don’t disagree with Krebs (and see also this interesting critique of government policy by a former Home Office civil servant), there is one dimension to all this that is inescapably political rather than scientific: the need to provide Alan Johnson with some kind of face-saving exit strategy that also safeguards the place of science in the policymaking process – and, ideally, nudges the UK towards an approach to drugs control that is at least slightly more sane.
Right now, after all, we have a situation in which the Serious Organised Crime Agency trumpets that its work has “sent cocaine prices soaring” – but the actual effect is that dealers’ profit margins are increasing, while the product they sell becomes less pure and more dangerous; in which Portugal’s strategy of decriminalising all drus has proved “a resounding success” according to a recent independent study – but other European governments don’t want to know; and above all, in which countries like Mexico, Guinea-Bissau and Afghanistan carry the can for OECD governments’ refusal to face facts, and slide ever closer to becoming hollowed-out or outright failed states.
So how to start to reorient drugs policy – given that, as Alan Johnson has just demonstrated so clearly, politicians manifestly feel unwilling or unable to persuade the public of the need for a more rational and effective approach?







